Erlotinib/osimertinib/rociletinibAcquired osimertinib resistance and various other toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1780卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71646-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：155 / 155

相关论文

共 50 条

[1] Erlotinib/osimertinib/rociletinibAcquired drug resistance in metastatic lung adenocarcinoma: case report
[J]. Reactions Weekly, 2018, 1693 (1) : 200 - 200
[2] Osimertinib/gefitinib/erlotinibDevelopment of resistance to osimertinib, gefitinib and erlotinib: case report
[J]. Reactions Weekly, 2017, 1654 (1) : 269 - 269
[3] Afatinib/erlotinib/osimertinibVarious toxicities and developement of drug resistance to afatinib and osimertinib: case report
[J]. Reactions Weekly, 2018, 1697 (1) : 22 - 22
[4] Osimertinib/selpercatinibVarious toxicities and acquired resistance: case report
[J]. Reactions Weekly, 2022, 1906 (1) : 322 - 322
[5] Osimertinib/trametinibVarious toxicities along with drug resistance: case report
[J]. Reactions Weekly, 2019, 1777 (1) : 189 - 189
[6] Crizotinib/erlotinib interactionDrug resistance and various other toxicities: case report
[J]. Reactions Weekly, 2015, 1567 (1) : 74 - 74
[7] Gefitinib/osimertinib/pemetrexedVarious toxicities: case report
[J]. Reactions Weekly, 2021, 1863 (1) : 166 - 166
[8] Dabrafenib/osimertinib/trametinibVarious toxicities: case report
[J]. Reactions Weekly, 2020, 1788 (1) : 86 - 86
[9] Dabrafenib/osimertinib/trametinibVarious toxicities: case report
[J]. Reactions Weekly, 2021, 1875 (1) : 114 - 114
[10] Gefitinib/osimertinib/vemurafenibVarious toxicities: case report
[J]. Reactions Weekly, 2022, 1907 (1) : 226 - 226

← 1 2 3 4 5 →